{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:20:16Z","timestamp":1783603216459,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41409-026-02876-3","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:50:15Z","timestamp":1777366215000},"page":"847-851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease"],"prefix":"10.1038","volume":"61","author":[{"given":"Reem","family":"Alasbali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phavina","family":"Akhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6026-1347","authenticated-orcid":false,"given":"Bader","family":"Alahmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0974-1249","authenticated-orcid":false,"given":"Josu","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"DeBaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel","family":"Samarkandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"El Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-8405","authenticated-orcid":false,"given":"Mostafa","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tusneem","family":"Elhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazza","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-7370","authenticated-orcid":false,"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Almohareb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0484-5903","authenticated-orcid":false,"given":"Adetola A.","family":"Kassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7577-0152","authenticated-orcid":false,"given":"Ali","family":"AlAhmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"2876_CR1","doi-asserted-by":"publisher","unstructured":"Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease.2017; 376: 1561-73. https:\/\/doi.org\/10.1056\/NEJMra1510865.","DOI":"10.1056\/NEJMra1510865"},{"key":"2876_CR2","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","volume":"110","author":"F Bernaudin","year":"2007","unstructured":"Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110:2749\u201356.","journal-title":"Blood"},{"key":"2876_CR3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","volume":"129","author":"E Gluckman","year":"2017","unstructured":"Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, et al. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood. 2017;129:1548\u201356.","journal-title":"Blood"},{"key":"2876_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/ajh.25202","volume":"93","author":"S Chaturvedi","year":"2018","unstructured":"Chaturvedi S, Ghafuri DL, Jordan N, Kassim A, Rodeghier M, DeBaun MR. Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: A retrospective-prospective cohort study. Am J Hematol. 2018;93:1153\u201360.","journal-title":"Am J Hematol"},{"key":"2876_CR5","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1056\/NEJMoa035477","volume":"350","author":"MT Gladwin","year":"2004","unstructured":"Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886\u201395.","journal-title":"N Engl J Med"},{"key":"2876_CR6","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood-2015-05-644435","volume":"126","author":"AA Kassim","year":"2015","unstructured":"Kassim AA, Payne AB, Rodeghier M, Macklin EA, Strunk RC, DeBaun MR. Low forced expiratory volume is associated with earlier death in sickle cell anemia. Blood. 2015;126:1544\u201350.","journal-title":"Blood"},{"key":"2876_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/bjh.12024","volume":"159","author":"AC McClellan","year":"2012","unstructured":"McClellan AC, Luthi JC, Lynch JR, Soucie JM, Kulkarni R, Guasch A, et al. High one year mortality in adults with sickle cell disease and end-stage renal disease. Br J Haematol. 2012;159:360\u20137.","journal-title":"Br J Haematol"},{"key":"2876_CR8","first-page":"1639","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639\u201344.","journal-title":"Life expectancy and risk factors for early death. N Engl J Med"},{"key":"2876_CR9","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(19)30154-1","volume":"6","author":"M Eapen","year":"2019","unstructured":"Eapen M, Brazauskas R, Walters MC, Bernaudin F, Bo-Subait K, Fitzhugh CD, et al. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study. Lancet Haematol. 2019;6:e585\u201396.","journal-title":"Lancet Haematol"},{"key":"2876_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2014.7192","volume":"312","author":"MM Hsieh","year":"2014","unstructured":"Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, et al. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA. 2014;312:48\u201356","journal-title":"JAMA"},{"key":"2876_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bjh.17311","volume":"192","author":"M Alzahrani","year":"2021","unstructured":"Alzahrani M, Damlaj M, Jeffries N, Alahmari B, Singh A, Rondelli D, et al. Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres. Br J Haematol. 2021;192:761\u20138.","journal-title":"Br J Haematol"},{"key":"2876_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.seminhematol.2018.04.011","volume":"55","author":"GMT Guilcher","year":"2018","unstructured":"Guilcher GMT, Truong TH, Saraf SL, Joseph JJ, Rondelli D, Hsieh MM. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease. Semin Hematol. 2018;55:87\u201393.","journal-title":"Semin Hematol"},{"key":"2876_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bbmt.2015.08.036","volume":"22","author":"SL Saraf","year":"2016","unstructured":"Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, et al. Nonmyeloablative Stem Cell Transplantation with Alemtuzumab\/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biol Blood Marrow Transplant. 2016;22:441\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2876_CR14","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1182\/blood.2023023301","volume":"143","author":"AA Kassim","year":"2024","unstructured":"Kassim AA, de la Fuente J, Nur E, Wilkerson KL, Alahmari AD, Seber A, et al. An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease. Blood. 2024;143:2654\u201365.","journal-title":"Blood"},{"key":"2876_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/asheducation-2014.1.210","volume":"2014","author":"JC Wood","year":"2014","unstructured":"Wood JC. Guidelines for quantifying iron overload. Hematology Am Soc Hematol Educ Program. 2014;2014:210\u20135.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2876_CR16","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1200\/JCO.22.01203","volume":"41","author":"M Eapen","year":"2023","unstructured":"Eapen M, Brazauskas R, Williams DA, St Walters MC, Martin A, Jacobs BL, et al. Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. J Clin Oncol. 2023;41:2227\u201337.","journal-title":"J Clin Oncol"},{"key":"2876_CR17","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1182\/blood.2022017960","volume":"140","author":"RA Lawal","year":"2022","unstructured":"Lawal RA, Mukherjee D, Limerick EM, Coles W, Hsieh MM, Dillon LW, et al. Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism. Blood. 2022;140:2514\u201318.","journal-title":"Blood"},{"key":"2876_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.46989\/001c.90837","volume":"5","author":"JW Jacobs","year":"2023","unstructured":"Jacobs JW, Adkins BD, Stephens LD, Woo JS, Booth GS. Risks and benefits of cannabis as a pain control modality in patients with sickle cell disease. Clin Hematol Int. 2023;5:47\u201350.","journal-title":"Clin Hematol Int"},{"key":"2876_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s44228-022-00022-6","volume":"4","author":"E Popham","year":"2022","unstructured":"Popham E, Moeller K, Raj A. Effects of Erythrocytapheresis Procedures on Delayed Bone Marrow Conversion in Sickle Cell Disease. Clin Hematol Int. 2022;4:144\u20137.","journal-title":"Clin Hematol Int"},{"key":"2876_CR20","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","volume":"388","author":"J Bolanos-Meade","year":"2023","unstructured":"Bolanos-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, et al. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. N Engl J Med. 2023;388:2338\u201348.","journal-title":"N Engl J Med"},{"key":"2876_CR21","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41409-021-01302-0","volume":"56","author":"LVE Oostenbrink","year":"2021","unstructured":"Oostenbrink LVE, Pool ES, Jol-van der Zijde CM, Jansen-Hoogendijk AM, Vervat C, van Halteren AGS, et al. Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide. Bone Marrow Transplant. 2021;56:2203\u201311.","journal-title":"Bone Marrow Transplant"},{"key":"2876_CR22","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1182\/blood.2023023660","volume":"144","author":"LS Kean","year":"2024","unstructured":"Kean LS, Burns LJ, Kou TD, Kapikian R, Lozenski K, Langston A, et al. Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation. Blood. 2024;144:1834\u201345.","journal-title":"Blood"},{"key":"2876_CR23","doi-asserted-by":"publisher","first-page":"e13222.","DOI":"10.1111\/tid.13222","volume":"22","author":"DA Patel","year":"2020","unstructured":"Patel DA, Dhedin N, Chen H, Karnik L, Gatwood K, Culos K, et al. Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease. Transpl Infect Dis. 2020;22:e13222.","journal-title":"Transpl Infect Dis"},{"key":"2876_CR24","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1172\/JCI124218","volume":"129","author":"LP Wachsmuth","year":"2019","unstructured":"Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG. Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest. 2019;129:2357\u201373.","journal-title":"J Clin Invest"},{"key":"2876_CR25","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med. 2017;377:2433\u201344.","journal-title":"N Engl J Med"},{"key":"2876_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","volume":"60","author":"JR Passweg","year":"2025","unstructured":"Passweg JR, Baldomero H, Atlija M, Kleovoulou I, Witaszek A, Alexander T, et al. The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT. Bone Marrow Transplant. 2025;60:519\u201328.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02876-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02876-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02876-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:59:22Z","timestamp":1783601962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02876-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2876"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02876-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}